Alfa eCare Americas ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.6% 13.6% 11.6% 9.6% 9.9%  
Credit score (0-100)  9 15 20 24 25  
Credit rating  B BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -0.6 15.9 16.0 12.0 30.9  
EBITDA  -0.6 15.9 16.0 12.0 30.9  
EBIT  -0.6 15.9 16.0 12.0 30.9  
Pre-tax profit (PTP)  -1.1 15.0 15.4 12.6 34.8  
Net earnings  -0.9 11.7 12.0 9.8 27.2  
Pre-tax profit without non-rec. items  -1.1 15.0 15.4 12.6 34.8  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  84.9 96.6 62.0 59.8 77.2  
Interest-bearing liabilities  0.0 0.0 0.0 12.8 30.3  
Balance sheet total (assets)  89.9 106 73.3 79.6 116  

Net Debt  -78.5 -94.3 -63.9 -46.0 -39.9  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -0.6 15.9 16.0 12.0 30.9  
Gross profit growth  0.0% 0.0% 0.6% -24.7% 156.5%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  90 106 73 80 116  
Balance sheet change%  -3.3% 18.2% -31.1% 8.7% 45.2%  
Added value  -0.6 15.9 16.0 12.0 30.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.7% 16.2% 17.8% 16.5% 35.7%  
ROI %  -0.7% 17.5% 20.2% 18.7% 38.7%  
ROE %  -1.0% 12.9% 15.2% 16.2% 39.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  95.5% 96.0% 93.9% 78.1% 69.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  12,346.9% -592.8% -399.4% -381.6% -129.0%  
Gearing %  0.0% 0.0% 0.0% 21.4% 39.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  22.5 26.6 18.3 4.7 3.4  
Current Ratio  17.8 11.0 6.5 4.0 3.0  
Cash and cash equivalent  78.5 94.3 63.9 58.8 70.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  84.9 96.6 62.0 59.8 77.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0